Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells. In normal mouse hematopoietic stem cells, the process of self-renewal involves the beta-catenin-signaling pathway. We investigated whether leukemic stem cells in CML also use the beta-catenin pathway for self-renewal. METHODS: We used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases of CML and from normal marrow. BCR-ABL, beta-catenin, and LEF-1 transcripts were compared by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors. Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear beta-catenin in these cells. In vitro replating assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on beta-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the beta-catenin pathway. RESULTS: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear beta-catenin as compared with the levels in progenitors from normal marrow. Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin. CONCLUSIONS: Activation of beta-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both myelodysplastic syndrome (Pang et al., 2013) and acute and chronic myelogenous leukemias begin with nonlethal mutations in the HSC pool, often leading to successful expansion of mutant HSC clones at the expense of normal HSC, and which progress eventually to leukemia (Corces-Zimmerman et al., 2014; Jamieson et al., 2004; Jan et al., 2012)”
From Quiescent Hematopoietic Stem Cells Accumulate DNA Damage during Aging that Is Repaired upon Entry into Cell Cycle (2014) · cites this paper as Jamieson et al., 2004
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
In the citing paper
“Although CML is considered a HSC-initiated disease, studies indicate that granulocyte-monocyte progenitors isolated from advanced-phase CML patients reacquire self-renewal properties and therefore may also serve as LSC.6”
From Rac2 GTPase deficiency depletes BCR-ABL+ leukemic stem cells and progenitors in vivo (2010) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
ROWLEY, J. D. (1973) · Nature · doi:10.1038/243290a0 · Cited by 4,291
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,942
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification
Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N., & Sawyers, C. L. (2001) · Science · doi:10.1126/science.1062538 · Cited by 3,104
Self-citationConstitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon Carcinoma
Korinek, V., Barker, N., Morin, P. J., van Wichen, D., de Weger, R., Kinzler, K. W., Vogelstein, B., & Clevers, H. (1997) · Science · doi:10.1126/science.275.5307.1784 · Cited by 2,905
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Akashi, K., Traver, D., Miyamoto, T., & Weissman, I. L. (2000) · Nature · doi:10.1038/35004599 · Cited by 2,617
Self-citationA minute chromosome in human chronic granulocytic leukemia
Nowell̀, P. C. (1960) · Science · Cited by 2,269
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Self-citationA role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159
Self-citation
Cited by
Items 301–400 of 1,000
Cancer stem cells: the lessons from pre‐cancerous stem cells
Gao, J. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00170.x · Cited by 107
“For an example, in blast-crisis chronic myelogenous leukemia (CML), the granulocyte-macrophage progenitors are able to retrodifferentiate into leukaemic stem cells (LSCs) through acquiring the capacity of self-renewal [72].”
Highly penetrant myeloproliferative disease in the Ts65Dn mouse model of Down syndrome
Kirsammer, G., Jilani, S., Liu, H., Davis, E., Gurbuxani, S., Le Beau, M. M., & Crispino, J. D. (2008) · Blood · doi:10.1182/blood-2007-04-085670 · Cited by 107
Hosen, N., Yamane, T., Muijtjens, M., Pham, K., Clarke, M. F., & Weissman, I. L. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0229 · Cited by 110
Mechanisms of resistance to BCR–ABL TKIs and the therapeutic strategies: A review
Yang, K., & Fu, L. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.11.001 · Cited by 119
“[93] Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, et al.”
BackgroundAberrant cytokine signaling in leukemia
Etten, R. A. V. (2007) · Oncogene · doi:10.1038/sj.onc.1210758 · Cited by 121
“Leukemic GMP from CML blast crisis patients also exhibited self-renewal in a replating assay that was reduced by enforced expression of axin, an inhibitor of β-catenin signaling (Jamieson et al., 2004).”
BackgroundCompartmental Architecture and Dynamics of Hematopoiesis
Dingli, D., Traulsen, A., & Pacheco, J. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000345 · Cited by 105
“and ii) the fact that the amplification that occurs in the bone marrow dilutes the progenitor cells making morphologic identification of these cells unfeasible. With few exceptions, many compartment (stage) specific replication rates remain undetermined despite the importance of these parameters, since the size of any…”
BackgroundThe cancer stem cell paradigm: a new understanding of tumor development and treatment
Ebben, J. D., Treisman, D. M., Zorniak, M., Kutty, R. G., Clark, P. A., & Kuo, J. S. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14712598.2010.485186 · Cited by 121
“described conversion of a committed granulocyte macrophage progenitor to leukemic stem cell through expression of MLL-AF9 fusion protein [85]; similar leukemiadriving progenitors have been inferred in human leukemias through surface marker analysis [86].”
BackgroundThe Cancer Stem Cell Hypothesis: A Guide to Potential Molecular Targets
Allegra, A., Alonci, A., Penna, G., Innao, V., Gerace, D. G., Rotondo, F., & Musolino, C. (2014) · Cancer Investigation · doi:10.3109/07357907.2014.958231 · Cited by 117
Dan, L., Klimenkova, O., Klimiankou, M., Klusman, J.-H., van den Heuvel-Eibrink, M. M., Reinhardt, D., Welte, K., & Skokowa, J. (2012) · Haematologica · doi:10.3324/haematol.2011.055236 · Cited by 103
A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary Gland
Cai, S., Kalisky, T., Sahoo, D., Dalerba, P. D., Feng, W., Lin, Y., Qian, D., Kong, A., Yu, J. J., Wang, F., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.11.007 · Cited by 114
“Normal stem cells are thought to be targets for oncogenic transformation and stem cell programs are often used by cancer cells (Behjati et al., 2014; Jamieson et al., 2004; Jan et al., 2012; Shimono et al., 2009).”
Treatment for chronic myelogenous leukemia: the long road to imatinib
Hunter, T. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31691 · Cited by 103
Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10
Oakley, K., Han, Y., Vishwakarma, B. A., Chu, S., Bhatia, R., Gudmundsson, K. O., Keller, J. R., Chen, X., Vasko, V. V., Jenkins, N. A., et al. (2012) · Blood · doi:10.1182/blood-2011-10-388710 · Cited by 105
The Biology of CML Blast Crisis
Radich, J. P. (2007) · Hematology · doi:10.1182/asheducation-2007.1.384 · Cited by 129
“Wnt/βcatenin signaling is thought to be important in cell selfrenewal, and mutations in β-catenin have been found in various epithelial solid tumors.48-50 Aberrant Wnt/β-catenin signaling has thus been demonstrated in CML and TALL.51,52 In CML, activation of the WNT/β-catenin pathway was observed in primary cell sampl…”
BackgroundMyeloid Cell Origins, Differentiation, and Clinical Implications
Weiskopf, K., Schnorr, P. J., Pang, W. W., Chao, M. P., Chhabra, A., Seita, J., Feng, M., & Weissman, I. L. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0031-2016 · Cited by 103
“In MDS, there is a speci fi c and significant reduction in the number of GMPs in the bone marrow of low-risk, or early-stage, patients (77) (Fig.”
BackgroundInfluentialAn evolutionary perspective on chronic myelomonocytic leukemia
Itzykson, R., & Solary, É. (2013) · Leukemia · doi:10.1038/leu.2013.100 · Cited by 116
Wnt Signaling, Stem Cells, and the Cellular Origin of Breast Cancer
Lindvall, C. J., Bu, W., Williams, B. O., & Li, Y. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0025-3 · Cited by 113
“events may also de-differentiate more committed cells to form cancers harboring mixed cell lineages [112–114].”
BackgroundWnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia
Corrêa, S., Binato, R., Rocher, B. D., Castelo-Branco, M. T. L., Pizzatti, L., & Abdelhay, E. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-303 · Cited by 116
Wang, M., Tang, D., Shu, B., Wang, B., Jin, H., Hao, S., Dresser, K., Shen, J., Im, H., Sampson, E. R., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34469 · Cited by 116
Jiang, Q., Isquith, J. M., Zipeto, M., Diep, R. H., Pham, J., Santos, N. P. D., Reynoso, E., Chau, J., Leu, H. S., Lazzari, E., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.11.017 · Cited by 101
“Although no significant change was observed in total human CD45+ cells (Figures S3A-C), FACS analysis revealed that miR-26a expression significantly reduced engraftment of granulocyte-macrophage progenitors (GMP, CD45+Lin−CD34+CD38+CD123+CD45RA +) that harbored LSC self-renewal capacity (Abrahamsson et al., 2009; Jami…”
BackgroundBavaro, L., Martelli, M., Cavo, M., & Soverini, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246141 · Cited by 115
“The blastic clone may originate either at the level of the multipotent LSC (CD34+CD38-Lin-) or at the level of a more committed granulocyte-macrophage progenitor cell, where the activation of β-catenin [16,17] and of hairy enhancer of split 1 (Hes1) [18] appear to be among the key events responsible for the re-acquisi…”
BackgroundEvidence for MPL W515L/K mutations in hematopoietic stem cells in primitive myelofibrosis
Chaligné, R., James, C., Tonetti, C., Besancenot, R., Couedic, J. P. L., Fava, F., Mazurier, F., Godin, I., Maloum, K., Larbret, F., et al. (2007) · Blood · doi:10.1182/blood-2007-05-089003 · Cited by 119
Mizutani, T., Kondo, T., Darmanin, S., Tsuda, M., Tanaka, S., Tobiume, M., Asaka, M., & Ohba, Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0548 · Cited by 107
“Detection of imatinib resistance by Pickles In the clinical setting, IM-resistant cells, constituting a very small population of the entire CML cell pool at the initiation of IM therapy, would relapse and supersede due to the elimination of most IM-sensitive cells by the treatment (29, 30).”
BackgroundHan, L., Qiu, P., Zeng, Z., Jorgensen, J. L., Mak, D. H. F., Burks, J. K., Schober, W. D., McQueen, T. J., Cortes, J. E., Tanner, S. D., et al. (2015) · Cytometry Part A · doi:10.1002/cyto.a.22628 · Cited by 104
“These LSCs possess unique properties, including specific signaling pathways (13,14) and gene signatures (16).”
BackgroundOncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
Sabnis, A. J., Cheung, L. S., Dail, M., Kang, H. C., Santaguida, M. A., Hermiston, M. L., Passegue, E. A., Shannon, K., & Braun, B. S. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000059 · Cited by 106
“chronic myeloid leukemia in blast transformation [62], and”
BackgroundThe tumor microenvironment shapes hallmarks of mature B-cell malignancies
Shain, K. H., Dalton, W. S., & Tao, J. (2015) · Oncogene · doi:10.1038/onc.2014.403 · Cited by 114
Ran, D., Schubert, M., Pietsch, L., Taubert, I., Wuchter, P., Eckstein, V., Bruckner, T. M., Zoeller, M., & Ho, A. D. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.10.001 · Cited by 112
“Regardless of whether LSC directly derive from primitive HSC that escape regulatory mechanisms [4,24] or arise from committed progenitor cells that reacquire stem cell capacities en route [25–27], they seem to share many features of primitive HSC that have slow divisional kinetics, are more adherent to the stem cell n…”
BackgroundThe Apcmin mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS
Lane, S. W., Sykes, S. M., Al-Shahrour, F., Shterental, S., Paktinat, M., Lo Celso, C., Jesneck, J. L., Ebert, B. L., Williams, D. A., & Gilliland, D. G. (2010) · Blood · doi:10.1182/blood-2009-11-251728 · Cited by 99
The bone marrow microenvironment as a sanctuary for minimal residual disease in CML
Nair, R. R., Tolentino, J., & Hazlehurst, L. A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.003 · Cited by 99
“in the acquisition of ‘stemness’ in these CML cells [70,71].”
BackgroundDifferentiation and transdifferentiation potentials of cancer stem cells
Huang, Z., Wu, T., Liu, A. Y., & Ouyang, G. (2015) · Oncotarget · doi:10.18632/oncotarget.6098 · Cited by 103
“In CML patients, granulocyte-macrophage progenitors serve as leukemia stem cell candidates and differentiate and promote progression of CML into blast crisis stage [28].”
BackgroundLin, T. L., Wang, Q., Brown, P. A., Peacock, C. D., Merchant, A. A., Brennan, S. K., Jones, E., McGovern, K., Watkins, D. N., Sakamoto, K. M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015262 · Cited by 98
Nievergall, E., Ramshaw, H. S., Yong, A. S. M., Biondo, M., Busfield, S. J., Vairo, G., Lopez, A. F., Hughes, T. P., White, D. L., & Hiwase, D. K. (2014) · Blood · doi:10.1182/blood-2012-12-475194 · Cited by 98
Chang, J. S., Santhanam, R., Trotta, R., Neviani, P., Eiring, A. M., Briercheck, E., Ronchetti, M., Roy, D. C., Calabretta, B., Caligiuri, M. A., et al. (2007) · Blood · doi:10.1182/blood-2007-03-078303 · Cited by 98
Effect of transcription-factor concentrations on leukemic stem cells
Rosenbauer, F., Koschmieder, S., Steidl, U., & Tenen, D. G. (2005) · Blood · doi:10.1182/blood-2005-02-0717 · Cited by 98
Fiskus, W., Sharma, S., Saha, S., Shah, B., Devaraj, S. G. T., Sun, B., Horrigan, S., Leveque, C., Zu, Y., Iyer, S., et al. (2015) · Leukemia · doi:10.1038/leu.2014.340 · Cited by 98
Guo, W., Lasky, J. L., & Wu, H. (2006) · Pediatric Research · doi:10.1203/01.pdr.0000203592.04530.06 · Cited by 120
“Of those self-renewal regulators, the polycomb family transcriptional repressor Bmi-1 and Wnt/ -catenin signaling pathway have recently been studied in the regulation of CSC self-renewal (25,36).”
BackgroundC/EBPα and the pathophysiology of acute myeloid leukemia
Mueller, B. U., & Pabst, T. (2005) · Current Opinion in Hematology · doi:10.1097/01.moh.0000190110.08156.96 · Cited by 112
GLI2 inhibition abrogates human leukemia stem cell dormancy
Sadarangani, A., Pineda, G., Lennon, K. M., Chun, H.-J. E., Shih, A. Y., Schairer, A., Court, A. C., Goff, D. J., Prashad, S., Geron, I., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0453-9 · Cited by 106
“Deregulation of critical stem cell processes, such as selfrenewal and dormancy, in hematopoietic progenitors contributes to the generation of leukemia stem cells (LSC) that are impervious to therapies that target dividing cells [2-14].”
BackgroundInfluentialInhibition of the Bcl-x L Deamidation Pathway in Myeloproliferative Disorders
Zhao, R., Follows, G., Beer, P. A., Scott, L. M., Huntly, B. J. P., Green, A. R., & Alexander, D. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804953 · Cited by 109
Baba, Y., Garrett, K. P., & Kincade, P. W. (2005) · Immunity · doi:10.1016/j.immuni.2005.10.009 · Cited by 115
“Disregulation of the Wnt/β-catenin pathway may be particularly important in leukemia (Serinsoz et al., 2004; Chung et al., 2002; Jamieson et al., 2004; Lu et al., 2004; Shackelford et al., 2003).”
BackgroundWarr, M. R., Pietras, E. M., & Passegué, E. (2011) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.145 · Cited by 112
Wnt/β‐catenin signalling induces MLL to create epigenetic changes in salivary gland tumours
Wend, P., Fang, L., Zhu, Q., Schipper, J. H., Loddenkemper, C., Kosel, F., Brinkmann, V., Eckert, K., Hindersin, S., Holland, J. D., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.127 · Cited by 95
“Similarly, specific mutations of b -catenin bestow self-renewal properties to chronic myeloid leukaemia cells (Jamieson et al , 2004).”
Stochastic Dynamics of Hematopoietic Tumor Stem Cells
Dingli, D., Traulsen, A., & Pacheco, J. M. (2007) · Cell Cycle · doi:10.4161/cc.6.4.3853 · Cited by 95
GATA-2 regulates granulocyte-macrophage progenitor cell function
Rodrigues, N. P., Boyd, A. S., Fugazza, C., May, G. E., Guo, Y., Tipping, A. J., Scadden, D. T., Vyas, P., & Enver, T. (2008) · Blood · doi:10.1182/blood-2008-01-136564 · Cited by 107
Ågerstam, H., Hansen, N., von Palffy, S., Sandén, C., Reckzeh, K., Karlsson, C., Lilljebjörn, H., Landberg, N., Askmyr, M., Högberg, C., et al. (2016) · Blood · doi:10.1182/blood-2015-11-679985 · Cited by 98
Li, J., Kent, D. G., Godfrey, A. L., Manning, H., Nangalia, J., Aziz, A., Chen, E., Saeb-Parsy, K., Fink, J., Sneade, R., et al. (2014) · Blood · doi:10.1182/blood-2013-06-510222 · Cited by 94
MicroRNA Regulation of Human Breast Cancer Stem Cells
Shimono, Y., Mukohyama, J., Nakamura, S.-I., & Minami, H. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm5010002 · Cited by 101
“For example, during the progression to blast crisis in chronic myelogenous leukemia, additional events, including the activation of β-catenin, occur in the granulocyte–macrophage progenitor population, allowing the progenitor cells, not hematopoietic stem cells (HSCs), to become leukemic stem cells [11].”
Syngeneic Mouse Models of Oral Cancer Are Effectively Targeted by Anti–CD44-Based NIR-PIT
Nagaya, T., Nakamura, Y., Okuyama, S., Ogata, F., Maruoka, Y., Choyke, P. L., Allen, C. T., & Kobayashi, H. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0333 · Cited by 94
“only); (3) NIR light exposure only, NIR light was administered at 50 J/cm(2) on day 0 and 100 J/cm(2) on day 1 (NIR light only); (4) 100 μg of anti-CD44-IR700 i.”
BackgroundLane, S., & Gilliland, D. G. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.12.001 · Cited by 113
BCR-ABL-transformed GMP as myeloid leukemic stem cells
Minami, Y., Stuart, S. A., Ikawa, T., Jiang, Y. D., Banno, A., Hunton, I. C., Young, D. J., Naoe, T., Murre, C., Jamieson, C. H. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808303105 · Cited by 104
“In CML blast crisis patients, granulocyte macrophage progenitors (GMP) with an aberrant potential for self-renewal were detected (9).”
BackgroundMethodResultRehe, K., Wilson, K., Bomken, S. N., Williamson, D., Irving, J. A. E., den Boer, M. L., Stanulla, M., Schrappe, M., Hall, A. G., Heidenreich, O. T., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201703 · Cited by 113
“As shown in chronic myeloid leukaemia, secondary events during malignant progression may lead to acquisition or expansion of the cancer stem cell phenotype in malignant cells ‘downstream’ of the cell of origin (Jamieson et al, 2004).”
Focus on myeloproliferative diseases and myelodysplastic syndromes
Etten, R. A. V., & Shannon, K. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.12.004 · Cited by 93
Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors
Angstreich, G. R., Matsui, W. H., Huff, C. A., Vala, M. S., Barber, J., Hawkins, A. L., Griffin, C. A., Smith, B. D., & Jones, R. J. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05606.x · Cited by 95
“The cellular expansion in CML occurs primarily in the differentiated progenitors, rather than the in stem cell pool (Bedi et al, 1993; Jamieson et al, 2004).”
BackgroundZhou, H., Mak, P. Y., Mu, H., Mak, D. H., Zeng, Z., Cortes, J., Liu, Q., Andreeff, M., & Carter, B. Z. (2017) · Leukemia · doi:10.1038/leu.2017.87 · Cited by 91
Aldehyde Dehydrogenase Activity Is a Biomarker of Primitive Normal Human Mammary Luminal Cells
Eirew, P. D., Kannan, N., Knapp, D. J. H. F., Vaillant, F., Emerman, J. T., Lindeman, G. J., Visvader, J. E., & Eaves, C. J. (2012) · Stem Cells · doi:10.1002/stem.1001 · Cited by 101
p63 in prostate biology and pathology
Grisanzio, C., & Signoretti, S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21555 · Cited by 103
“Alternatively, however, there is evidence that genetic/epigenetic changes occurring in committed progenitor cells can cause them to become neoplastic through dedifferentiation and acquisition of stem cell characteristics (i.e., self-renewal) [Jamieson et al., 2004].”
BackgroundKlein, S., McCormick, F. P., & Levitzki, A. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1651 · Cited by 98
“Recent evidence indicates that the putative cancer stem cells that cause blast-crisis CML might actually be progenitor cells (an early stage following commitment to differentiation) that have regained the ability to self-renew, by activating the WNT–β-catenin pathwa”
BackgroundHeuser, M., Yun, H., Berg, T., Yung, E., Argiropoulos, B., Kuchenbauer, F. C., Park, G., Hamwi, I., Palmqvist, L., Lai, C. K., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.020 · Cited by 99
“…additional studies in chronic myeloid leukemia patient samples or mouse models of human leukemia identified LICs with immunophenotypic characteristics of myeloid or even lymphoid progenitor cells (Deshpande et al., 2006; Jamieson et al., 2004; Kirstetter et al., 2008; Somervaille and Cleary, 2006).”
BackgroundEYA1 Phosphatase Function Is Essential to Drive Breast Cancer Cell Proliferation through Cyclin D1
Wu, K., Li, Z., Cai, S., Tian, L., Chen, K., Wang, J., Hu, J., Sun, Y., Li, X., Ertel, A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4078 · Cited by 90
Notch and Wnt signaling in T-lymphocyte development and acute lymphoblastic leukemia
Weerkamp, F., van Dongen, J. J. M., & Staal, F. J. T. (2006) · Leukemia · doi:10.1038/sj.leu.2404255 · Cited by 103
“reporting involvement of Wnt signaling in the proliferation of chronic myelogenous leukemia (CML) stem cells”
BackgroundStem cells in cancer: instigators and propagators?
Alison, M. R., Islam, S., & Wright, N. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.054296 · Cited by 105
“Other examples in which leukaemia is derived from progenitors include CML patients in blast crisis (the final phase in the evolution of leukaemia), in which GMPs can become self-renewing TPCs; this change is associated with elevated Wnt signalling in the GMPs (Jamieson et al., 2004).”
BackgroundChronic versus acute myelogenous leukemia
Jamieson, C. H. M., Weissman, I. L., & Passegue, E. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.12.005 · Cited by 89
Tonks, A., Pearn, L., Musson, M., Gilkes, A., Mills, K., Burnett, A. K., & Darley, R. L. (2007) · Leukemia · doi:10.1038/sj.leu.2404961 · Cited by 98
Glioma stem cells: Evidence and limitation
Fan, X., Salford, L. G., & Widegren, B. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.04.002 · Cited by 87
Mullighan, C. G., Williams, R. T., Downing, J. R., & Sherr, C. J. (2008) · Genes & Development · doi:10.1101/gad.1673908 · Cited by 96
Raaijmakers, M. H. G. P. (2007) · Leukemia · doi:10.1038/sj.leu.2404859 · Cited by 101
“Of note, K562 cells have been derived from a CML patient entering blast crisis in which the stem cell compartment shifts to the granulocyte-monocyte progenitor population”
BackgroundMelanoma stem cells: not rare, but well done
Girouard, S. D., & Murphy, G. F. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.50 · Cited by 105
Kent, D. G., Li, J., Tanna, H., Fink, J., Kirschner, K., Pask, D. C., Silber, Y., Hamilton, T. L., Sneade, R., Simons, B. D., et al. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001576 · Cited by 85
Pathways to Tumorigenesis—Modeling Mutation Acquisition in Stem Cells and Their Progeny
Ashkenazi, R., Gentry, S. N., & Jackson, T. L. (2008) · Neoplasia · doi:10.1593/neo.08572 · Cited by 85
“Recent experiments [51] show that while the oncogene Bcr-Abl, which is associated with CML, drastically alters Neoplasia Vol. 10, No. 11, 2008 Modeling Pathways of Tumorigenesis Ashkenazi et al. 1179 the rates of division and death in mutated stem cells, the oncogene HoxA9-Nup98 (associated with AML) does not affect c…”
BackgroundInfluentialKumari, A., Brendel, C. A., Hochhaus, A., Neubauer, A., & Burchert, A. (2011) · Blood · doi:10.1182/blood-2010-08-303495 · Cited by 93
Resistance to Imatinib: Mutations and Beyond
Rosée, P. G. L., & Deininger, M. W. (2010) · Seminars in Hematology · doi:10.1053/j.seminhematol.2010.06.005 · Cited by 86
Management of CML-blast crisis
Hehlmann, R., Saußele, S., Voskanyan, A. A., & Silver, R. T. (2016) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2016.10.005 · Cited by 88
New Opportunities and Challenges to Defeat Cancer Stem Cells
Ramos, E. K., Hoffmann, A. D., Gerson, S. L., & Liu, H. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.08.007 · Cited by 89
Bruns, I., Czibere, A. G., Fischer, J., Roels, F., Cadeddu, R.-P., Buest, S., Brünnert, D., Huenerlituerkoglu, A.-N., Stoecklein, N., Singh, R., et al. (2009) · Leukemia · doi:10.1038/leu.2008.392 · Cited by 90
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5
Liu, F., Kunter, G. M., Krem, M. M., Eades, W. C., Cain, J. A., Tomasson, M. H., Hennighausen, L. G., & Link, D. C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32704 · Cited by 97
“The capacity for self-renewal can be achieved either by transformation of HSCs with inherent self-renewal capacity or by the acquisition of this ability in committed progenitor populations during leukemogenesis (3).”
BackgroundNagano, H., Tomimaru, Y., Eguchi, H., Hama, N., Wada, H., Kawamoto, K., Kobayashi, S., Mori, M., & Doki, Y. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2037 · Cited by 85
Weissman, I. L. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505464112 · Cited by 83
“In every case the single HSC that had sustained the first mutation expanded by clonal competition at the “expense” of normal HSCs, but the total frequency of HSCs was not increased (23, 25); the early mutant cells were outcompeting the normal ones.”
BackgroundBMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells
Rizo, A., Horton, S. J., Olthof, S., Dontje, B., Ausema, A., van Os, R., van den Boom, V., Vellenga, E., de Haan, G., & Schuringa, J. J. (2010) · Blood · doi:10.1182/blood-2010-02-270660 · Cited by 83
β-Catenin/TCF-1 Pathway in T Cell Development and Differentiation
Ma, J., Wang, R., Fang, X., & Sun, Z. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9367-y · Cited by 83
“In addition, this pathway has been linked to pathogenesis of diseases such as colon carcinoma (Barker and Clevers 2006) and leukemia (Jamieson et al. 2004). β-catenin/TCF signaling is also required for hematopoietic stem cell self-renewal and the proliferation of progenitor cells.”
BackgroundInduction of Tumor Immunity Following Allogeneic Stem Cell Transplantation
Wu, C. J., & Ritz, J. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)90004-2 · Cited by 90
Tanno, T., Lim, Y., Wang, Q., Chesi, M., Bergsagel, P. L., Matthews, G., Johnstone, R. W., Ghosh, N., Borrello, I., Huff, C. A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-524025 · Cited by 84
“Therefore the functional properties of MM cells may not be confined to a specific phenotypic population but may differ depending on disease stage or specific genetic mutations as described in chronic myeloid leukemia.(44) We found that GDF15 preferentially Figure 5.”
BackgroundEmerging Roles of SIRT1 in Cancer Drug Resistance
Wang, Z., & Chen, W. (2013) · Genes & Cancer · doi:10.1177/1947601912473826 · Cited by 82
“CSCs may arise from self-renewing stem cells by the acquisition of mutations or from more differentiated cells after the gain of function of CSC properties.(94,95) CSCs are essential for cancer development and can serve as the source of primary cancer or a reservoir of cells with the capability of relapse or metastasi…”
BackgroundChomel, J., & Turhan, A. G. (2011) · Oncotarget · doi:10.18632/oncotarget.333 · Cited by 96
“self-renewing) through an activation of β-catenin [70].”
Aberrant Wnt Signaling in Leukemia
Staal, F. J. T., Famili, F., García-Pérez, L., & Pike‐Overzet, K. (2016) · Cancers · doi:10.3390/cancers8090078 · Cited by 91
Cancer stem cells with genetic instability: the best vehicle with the best engine for cancer
Lagasse, E. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303068 · Cited by 87
Oehler, V. G., Guthrie, K. A., Cummings, C. L., Sabo, K. M., Wood, B. L., Gooley, T. A., Yang, T., Epping, M. T., Shou, Y., Pogosova‐Agadjanyan, E. L., et al. (2009) · Blood · doi:10.1182/blood-2008-07-170282 · Cited by 83
BCR-ABL enhances differentiation of long-term repopulating hematopoietic stem cells.
Schemionek, M., Elling, C., Steidl, U., Bäumer, N., Hamilton, A., Spieker, T., Göthert, J. R., Stehling, M., Wagers, A., Huettner, C. S., et al. (2010) · Blood · doi:10.1182/blood-2009-04-215376 · Cited by 80
The presence of stem cell marker‐expressing cells is not prognostically significant in glioblastomas
Kim, K., Lee, K., Kim, H., Moon, K., Jung, T., Jung, S., & Lee, M. (2011) · Neuropathology · doi:10.1111/j.1440-1789.2010.01194.x · Cited by 80
Cancer stem cells in multiple myeloma
Ghosh, N., & Matsui, W. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.08.005 · Cited by 46
“However, it is unclear whether all human cancers arise from normal self-renewing cells since studies in chronic myeloid leukemia and model systems of AML have demonstrated that specific genetic or epigenetic alterations may induce self-renewal in more differentiated cells that normally have limited replicative potenti…”
BackgroundRegulation of hematopoiesis and the hematopoietic stem cell niche by Wnt signaling pathways
Nemeth, M. J., & Bodine, D. M. (2007) · Cell Research · doi:10.1038/cr.2007.69 · Cited by 106
Ma, G., Yasunaga, J., Fan, J., Yanagawa, S.-I., & Matsuoka, M. (2012) · Oncogene · doi:10.1038/onc.2012.450 · Cited by 89
The theoretical basis of cancer‐stem‐cell‐based therapeutics of cancer: can it be put into practice?
Sánchez-García, I., Vicente‐Dueñas, C., & Cobaleda, C. (2007) · BioEssays · doi:10.1002/bies.20679 · Cited by 87
“One example of such mechanism is the alteration of the b-catenin pathway in granulocyte-macrophage progenitors in chronic myelogenous leukaemia.((41)) In this context, one can hypothesize that the oncogenic defect does not have to immediately generate a CSC, but might give rise to a precancerous cell that, depending o…”
BackgroundBladder cancer stem cells: clonal origin and therapeutic perspectives
Li, Y., Lin, K., Yang, Z., Han, N., Quan, X., Guo, X., & Li, C. (2017) · Oncotarget · doi:10.18632/oncotarget.19112 · Cited by 85
“Also, Activated Gli1 was found in 85% of CD44+ tumor cells suggesting that Gli1 was a potential molecular target [85].”
BackgroundNormal Hematopoiesis Is a Balancing Act of Self-Renewal and Regeneration
Olson, O. C., Kang, Y.-A., & Passegué, E. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035519 · Cited by 76
Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia
Signer, R. A. J., Montecino-Rodriguez, E., Witte, O. N., McLaughlin, J., & Dorshkind, K. (2007) · Blood · doi:10.1182/blood-2007-01-069401 · Cited by 77
Mimeault, M., & Batra, S. K. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.12.001 · Cited by 85
Wnt inhibition leads to improved chemosensitivity in paediatric acute lymphoblastic leukaemia
Dandekar, S. C., Romanos‐Sirakis, E., Pais, F. M., Bhatla, T., Jones, C. L., Bourgeois, W., Hunger, S. P., Raetz, E. A., Hermiston, M. L., DasGupta, R., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.13011 · Cited by 82
“…malignancies (Staal & Clevers, 2005) including AML (Muller-Tidow et al, 2004; Wang et al, 2010), chronic lymphoid leukaemia (Lu et al, 2004), blast crisis of chronic myeloid leukaemia (Jamieson et al, 2004), multiple myeloma (Derksen et al, 2004) and, more recently, ALL (Khan et al, 2007).”
BackgroundTargeting survival pathways in chronic myeloid leukaemia stem cells
Sinclair, A., Latif, A. L., & Holyoake, T. L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12183 · Cited by 87
“A study by Jamieson et al. (2004) showed that the granulocytemacrophage progenitor pool from patients with CML BC and IM resistant CML had elevated levels of nuclear b-catenin as compared with normal marrow.”
BackgroundGehrke, I., Gandhirajan, R. K., & Kreuzer, K. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.08.003 · Cited by 85
Zhou, L. L., Zhao, Y. S., Ringrose, A., DeGeer, D., Kennah, E., Lin, A. E.-J., Sheng, G., Li, X., Turhan, A. G., & Jiang, X. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072316 · Cited by 74
Oncogenic mechanisms in myeloproliferative disorders
Delhommeau, F., Pisani, D. F., James, C., Casadevall, N., Constantinescu, S. N., & Vainchenker, W. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6272-7 · Cited by 93
Metadata
- Authors
- Jamieson, C. H. M., Ailles, L. E., Dylla, S. J., Muijtjens, M., Jones, C., Zehnder, J. L., Gotlib, J., Li, K., Manz, M. G., Keating, A., Sawyers, C. L., & Weissman, I. L.
- Affiliations
- Stanford Medicine (US)
- University of Toronto (CA)
- University of California, Los Angeles (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-08-12
- Volume
- 351
- Issue
- 7
- Pages
- 657-667
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2012962381
- Cited by
- 1,485
- References
- 58
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 19 · 2023: 36 · 2022: 27 · 2021: 33 · 2020: 40 · 2019: 37 · 2018: 40 · 2017: 53 · 2016: 80 · 2015: 74 · 2014: 81 · 2013: 95 · 2012: 114
- FWCI
- 55.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23HL04409, K23HL004409)
- National Cancer Institute (2PO1CA49605, CA 86017, CA 55209, R01CA086017, P01CA049605)
- National Institute of Allergy and Infectious Diseases (5 T32 AI07290, T32AI007290)
- Topics
- Health Sciences › Medicine › Hematology › Chronic Myeloid Leukemia Treatments
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Keywords
- chronic myeloid leukemia, blast crisis, leukemia stem cells, CFU-GM, β-catenin signaling, BCR-ABL, self-renewal, Axin, imatinib resistance, hematopoietic stem cells, myeloid progenitor cells
- MeSH terms
- Imatinib Mesylate, Adult, Aged, Antineoplastic Agents, Benzamides, Blast Crisis, Colony-Forming Units Assay, Cytoskeletal Proteins, DNA-Binding Proteins, Female, Granulocytes, Hematopoietic Stem Cells, Humans, Macrophages, Male, Middle Aged, Piperazines, Pyrimidines, RNA, Neoplasm, Transcription Factors, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Trans-Activators, Fusion Proteins, bcr-abl, Microscopy, Confocal, Drug Resistance, Neoplasm, Reverse Transcriptase Polymerase Chain Reaction, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.